Treatment psoriasis psoriatic arthritis interferon gamma placebo-controlled double-blind study patients psoriatic arthritis treatment open study patients months patients micrograms IFN gamma subcutaneous injections first weeks times week principal criterion evaluation therapeutic success arthritis improvement Ritchie joint pain index double-blind long-term study double-blind study interferon arm superior placebo arm significant one-side error probability chi-square test long-term study IFN gamma improvement portion patients first months therapy improvement third month patients responders first months deterioration disease treatment humoral inflammatory parameters therapy Regression skin manifestations IFN gamma capable psoriasis injection site Investigations IFN serum levels IFN antibodies synthetase levels serum mononuclear blood cells NK cell activity long-term therapy explanation loss efficacy months treatment 